Nanoviricides, inc. (NNVC)
CashFlow / Yearly
Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-8,424

-8,563

-10,304

-

-

-

-

-

-

-

Net loss

-

-

-

-10,724

-2,198

-13,601

-8,875

-6,207

-6,477

-4,744

Adjustments to reconcile net loss to net cash used in operating activities
Preferred shares issued for license

-

-

-

-

-

-

-

0

0

7

Preferred shares issued as compensation

237

524

1,272

882

877

2,123

445

982

0

1,220

Common shares issued as compensation and for services

282

266

328

345

279

434

-

-

-

-

Warrants issued for Series B Interest

-

-

-

56

0

0

-

-

-

-

Warrants granted to Scientific Advisory Board

5

16

37

42

59

199

141

211

205

204

Common shares issued as compensation and for services

-

-

-

-

-

-

163

253

1,865

467

Common shares issued for debenture interest

0

-60

-607

-660

-1,502

-2,605

-665

0

-

-

Common Stock issued upon cashless exercise of stock options

-

-

-

0

0

0

-

-

-

-

Reduction in leasehold improvements and fixtures and accumulated depreciation due to decommissioning of West Haven, CT facilities

-

-

-

332

0

0

-

-

-

-

Series A Preferred stock issued as discount on debentures

-

-

-

-

1,152

-

-

-

-

-

Bifurcation of embedded derivative

-

-

-

-

1,879

0

0

-

-

-

Issuance of Series C Debenture for deposit received

-

-

-

-

5,000

0

-

-

-

-

Allocation of proceeds from private placement to derivative liability warrants

-

-

-

-

-

5,740

-

-

-

-

Common stock issued for interest on debentures

-

-

-

-

-

-

-

0

0

-

Shares of common stock issued in connection with debenture offering

-

-

-

-

-

-

-

0

0

-

Common stock issued upon conversion of convertible debentures

-

-

-

-

-

-

-

0

0

-

Common stock issued upon conversion of Series C Preferred Stock

-

-

-

-

-

-

3,028

-

-

-

Common stock issued for services rendered

-

-

-

-

-

-

-

253

447

-

Common stock for interest

-

-

-

-

-

-

-

-

0

-

Preferred stock issued as compensation

-

-

-

-

-

-

-

982

1,418

-

Stock-based compensation expense

11

0

0

-

-

-

-

0

0

-

Warrants granted for severance agreement

0

53

0

0

-

-

-

-

-

-

Amortization of deferred compensation

-

-

-

-

-

-

-

-

0

0

Amortization of deferred compensation

-

-

-

-

-

-

-

0

-

-

Depreciation

687

671

654

651

294

203

210

210

518

82

Amortization

8

8

8

-

-

-

-

-

-

-

Amortization

-

-

-

8

8

8

8

8

8

7

Software disposal

-

-

-

26

0

0

-

-

-

-

Change in fair value of derivative liability

179

2,554

1,696

541

8,529

-1,443

-1,249

-172

-62

192

Amortization of debt discount convertible debentures

0

359

1,347

1,427

1,175

569

-

0

0

0

Loss on extinguishment of debt

0

-1,348

-332

0

-

-

-

-

-

-

Loss on extinguishment of Series C debenture

-

-

-

-

0

-

-

-

-

-

Amortization of debt discount convertible debentures

-

-

-

-

-

-

0

0

-

-

Discount on convertible debentures

-

-

-

-

-

-

-

-

0

0

Beneficial conversion feature of convertible debentures

-

-

-

-

-

-

-

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses

29

50

-29

5

106

56

284

-18

41

-38

Security deposit

-

-

-

-3

150

-150

-

-

-

-

Other current assets

-

-

-

-

-

-

0

0

-209

108

Deferred expenses

-

-

-

-

-

-

0

0

0

0

Other assets

21

-50

-40

-46

142

0

0

-

-

-

Prepaid expenses- related party

-

-

-

-

-

-

-344

0

-

-

Accounts payable

86

87

39

7

-286

113

24

158

-48

37

Accounts payable - related party

716

-233

-426

451

266

-114

-

-97

-730

892

Accrued expenses

-184

219

-1

7

-63

-112

107

69

-58

50

Deferred interest payable

0

-41

-166

-166

500

0

-

-

-

-

Collateral advance for affiliate

-

-

-

-

1,000

0

-

-

-

-

Accrued payroll to officers and related payroll tax expense

-

-

-

-

-

-

-

-

-

9

NET CASH USED IN OPERATING ACTIVITIES

-6,800

-7,775

-7,897

-6,829

-

-

-

-

-4,507

-2,047

Accrued payroll to officers and related payroll tax expense

-

-

-

-

-

-

-

-

-22

-

NET CASH USED IN OPERATING ACTIVITIES

-

-

-

-

-6,212

-6,333

-5,797

-4,217

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Collateral advance for affiliate

-

-

-

-

-

-

1,000

0

0

-

Purchase of property and equipment

73

241

164

476

6,760

5,231

64

23

152

561

NET CASH USED IN INVESTING ACTIVITIES

-

-

-

-

-

-

-

-

-194

-744

CASH FLOWS FROM FINANCING ACTIVITIES
Net proceeds from issuance of common stock and warrants

2,350

0

0

-

-

-

-

-

-

-

Purchase of trademark

-

-

-

-

-

-

-

35

41

183

NET CASH USED IN INVESTING ACTIVITIES

-

-

-

-

-5,760

-5,231

-1,064

-58

-

-

Repayment of Series B Debentures payable

0

0

1,000

0

0

-

-

-

-

-

Proceeds from issuance of convertible debentures

-

-

-

-

-

5,000

6,000

0

-

-

Proceeds from issuance of Convertible Preferred Series C stock, net

-

-

-

-

-

-

510

-

-

-

Proceeds from issuance of common stock and warrants in connection with private placements of common stock, net of issuance costs

-

-

-

-

-

28,602

0

0

0

1,432

Proceeds from exercise of warrants

-

-

-

-

6,743

735

0

-

-

-

Proceeds from exercise of stock options

-

-

-

-

-

-

-

0

0

0

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

60

2,076

Collection of stock subscriptions received

-

-

-

-

-

-

-

0

0

0

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

6,743

34,338

6,510

9,327

-

-

NET CASH PROVIDED BY FINANCING ACTIVITIES

2,350

0

-1,000

-

-

-

-

-

6,970

8,058

NET CHANGE IN CASH AND CASH EQUIVALENTS

-4,526

-8,017

-9,062

-

-

-

-

-

-

-

NET CHANGE IN CASH AND CASH EQUIVALENTS

-

-

-

-7,305

-5,229

22,773

-351

5,050

2,268

5,266

SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Interest paid

0

166

173

1,036

-

-

-

-

-

-

Interest paid

-

-

-

-

980

480

197

0

0

0

Income tax paid

0

0

0

0

0

0

0

0

0

0

Non-cash Financing and Investing Activities:
Common stock issued for debenture payment

0

4,605

5,000

0

-

0

0

-

-

-

Common stock issued for deferred interest

0

125

0

0

-

-

-

-

-

-

Series A Preferred stock issued for Series C debenture

0

314

0

0

-

-

-

-

-

-

Stock warrants granted to scientific advisory board

-

-

-

-

-

-

-

211

205

-

Stock warrants granted to brokers

-

-

-

-

-

-

-

0

0

-

Debt discount related to beneficial conversion feature of convertible debt

-

-

-

-

-

-

-

0

0

-

Stock Warrants issued in connection with Private Placement

-

-

-

-

-

-

-

0

0

-

Common stock issued for accounts payable

-

-

-

-

-

-

-

0

0

-

Common stock issued for equipment

-

-

-

-

-

-

-

0

0

-